LIVE

Serial Number

88886712

Owner

Y-mAbs Therapeutics, Inc

Attorney

Andrew N. Spivak

Filing Date

Apr 24, 2020

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

OMBLASTYS (OMBURTAMAB) Trademark

Serial Number: 88886712 • Registration: 6338259

OMBLASTYS (OMBURTAMAB) is a trademark filed by Y-mAbs Therapeutics, Inc on April 24, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Y-mAbs Therapeutics, Inc (19 trademarks)

230 Park Avenue, Suite 3350

Entity Type: 03

Legal Representation

Attorney of Record

Andrew N. Spivak

3,005 trademarks filed View all →

Correspondence Address

Andrew N. Spivak MOSAIC LEGAL GROUP, PLLC

5185 MACARTHUR BOULEVARD, NW, SUITE 350

WASHINGTON, DC 20016-3341

UNITED STATES

Trademark Details

Filing Date

April 24, 2020

Registration Date

May 4, 2021

Published for Opposition

February 16, 2021

Goods & Services

Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies

Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 4, 2026 REM1

REGISTERED-PRINCIPAL REGISTER

May 4, 2021 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 16, 2021 NPUB

PUBLISHED FOR OPPOSITION

Feb 16, 2021 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 27, 2021 NONP

ELECTRONIC RECORD REVIEW COMPLETE

Aug 27, 2020 FIXD

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Aug 21, 2020 ERRR

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 20, 2020 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 20, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 20, 2020 CRFA

ASSIGNED TO LIE

Aug 17, 2020 ALIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Jul 29, 2020 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jul 24, 2020 GNS3

LETTER OF SUSPENSION E-MAILED

Jul 24, 2020 GNSL

SUSPENSION LETTER WRITTEN

Jul 24, 2020 CNSL

EXAMINER'S AMENDMENT ENTERED

Jul 20, 2020 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 20, 2020 GNEN

EXAMINERS AMENDMENT E-MAILED

Jul 20, 2020 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jul 20, 2020 CNEA

ASSIGNED TO EXAMINER

Jul 17, 2020 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 7, 2020 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 6, 2020 NWOS

NEW APPLICATION ENTERED

Apr 28, 2020 NWAP

Related Trademarks

More from this Owner

SADA PRIT

Y-LABS

Y-PRIT

More in Same Class

LIQUID PRO